CTOs on the Move

Queens-Long Island Medical Group, P.C.

www.qlimg.com

 
Queens-Long Island Medical Group, P.C. is a Garden City, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.qlimg.com
  • 1000 Zeckendorf Blvd
    Garden City, NY USA 11530
  • Phone: 516.542.5500

Executives

Name Title Contact Details

Similar Companies

Wilson Ophthalmic Corp

Wilson Ophthalmic Corp is a Mustang, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wisconsin Women'S Health

Wisconsin Women'S Health is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tower Health

Tower Health is a regional integrated healthcare system that offers leading-edge, compassionate healthcare and wellness services to communities in Berks, Chester, Montgomery, and Philadelphia Counties. With nearly 12,000 team members, Tower Health consists of Reading Hospital in West Reading; Chestnut Hill Hospital in Philadelphia; Phoenixville Hospital in Phoenixville; Pottstown Hospital in Pottstown; and St. Christopher`s Hospital for Children, a partnership of Tower Health and Drexel University in Philadelphia. It also includes Reading Hospital Rehabilitation at Wyomissing; Reading Hospital School of Health Sciences in West Reading; home healthcare provided by Tower Health at Home; TowerDirect ambulance and emergency response; Tower Health Medical Group; and a network of 25 urgent care facilities across the Tower Health service area.

Nanoscope Therapeutics

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.

VersaSuite

VersaSuite is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.